Rchr
J-GLOBAL ID:200901045934575425   Update date: Oct. 09, 2024

Takahashi Yoshihisa

タカハシ ヨシヒサ | Takahashi Yoshihisa
Affiliation and department:
Job title: Professor
Research field  (2): Experimental pathology ,  Human pathology
Research keywords  (2): digestive organ ,  pathology
Research theme for competitive and other funds  (11):
  • 2022 - 2025 Inhibitory effects and therapeutic application of urolithin and ellagic acid on nonalcoholic fatty liver disease
  • 2021 - 2022 Expression and its significance of FGF21 and its receptor FGFR1 in liver tumors
  • 2018 - 2021 Inhibitory effects and treatment strategy of nonalcoholic steatohepatitis by polyamines
  • 2018 - 2019 Sex difference of model mice of nonalcoholic fatty liver disease by combination of genetics and nutrition
  • 2017 - 2018 Study on sex difference of model mice of nonalcoholic fatty liver disease
Show all
Papers (81):
  • Naoki Ohkura, Riyo Morimoto-Kamata, Yuichi Kamikubo, Yoshihisa Takahashi, Katsutaka Oishi. Hypofibrinolytic phenotype in Tsumura Suzuki Obese Diabetes (TSOD) mice unrelated to hyperglycemia. Drug discoveries & therapeutics. 2023. 17. 5. 346-350
  • Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano, Toshio Fukusato. Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors. Biomedicines. 2023. 11. 10. 2761-2761
  • Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano, Toshio Fukusato. Artificial intelligence and deep learning: New tools for histopathological diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Computational and Structural Biotechnology Journal. 2023. 21. 2495-2501
  • Erdenetsogt Dungubat, Hiroyuki Kusano, Ichiro Mori, Hirosuke Tawara, Mitsuko Sutoh, Naoki Ohkura, Masakatsu Takanashi, Masahiko Kuroda, Naoki Harada, Emiko Udo, et al. Age-dependent sex difference of non-alcoholic fatty liver disease in TSOD and db/db mice. PLOS ONE. 2022. 17. 12. e0278580-e0278580
  • Dariimaa Ganbat, Bat-Erdene Jugder, Lkhamaa Ganbat, Miki Tomoeda, Erdenetsogt Dungubat, Ambaga Miyegombo, Gantsetseg Garmaa, Yoshihisa Takahashi, Ryuji Fukuzawa, Ichiro Mori, et al. Use of the Naphthoquinone YM155 (Sepantronium Bromide) in the Treatment of Cancer: A Systematic Review and Meta-Synthesis. Oncologie. 2022. 24. 2. 195-225
more...
MISC (174):
  • 高橋芳久, エルデネツォグト・ドゥングバト, 福里利夫. Metabolic dysfunction-associated steatohepatitisモデルマウスに対するプトレシンの効果. 肝臓. 2024. 65. Suppl.1. A513-A513
  • エルデネツォグト・ドゥングバト, 梅村昌宏, 川田一仁, 福里利夫, 高橋芳久. 原発性胆汁性胆管炎、原発性硬化性胆管炎モデルマウスに対するハスカップ果実抽出物の効果. 肝臓. 2024. 65. Suppl.1. A352-A352
  • 森 グレイスリン 真理愛, エネレル・バトトゥグス, 伊知地梨咲, エルデネツォグト・ドゥングバト, 北山康彦, 田島康夫, 大東貴志, 相田真介, 福里利夫, 高橋芳久. 好酸性・顆粒状の細胞質と神経内分泌系への分化を伴った膀胱のinverted papilloma. 日本病理学会会誌. 2024. 113. 477-477
  • 伊知地梨咲, 森 グレイスリン 真理愛, エネレル・バトトゥグス, エルデネツォグト・ドゥングバト, 中澤匡男, 相田真介, 山下浩二, 福里利夫, 高橋芳久. 乳腺のneuroendocrine tumor. 日本病理学会会誌. 2024. 113. 476-476
  • エネレル・バトトゥグス, 伊知地梨咲, 森 グレイスリン 真理愛, エルデネツォグト・ドゥングバト, 草野広行, Bayart-Uils Bayar, Tudevdorj Sanjsambuu, darmaa Erdene, 福里利夫, 高橋芳久. 総胆管のinflammatory myofibroblastic tumor. 日本病理学会会誌. 2024. 113. 474-474
more...
Books (32):
  • Prime Archives in Biomedicine
    Vide Leaf 2024
  • Research Advances in Microbiology and Biotechnology, Vol. 9
    BP International 2024
  • Advances in Medicine
    Academic Reads 2023
  • Basic Protocols in Foods and Nutrition
    Springer Science + Business Media 2022
  • Highlights on Medicine and Medical Science, Vol. 9
    BP International 2021
more...
Lectures and oral presentations  (218):
  • Inhibitory effects of putrescine on metabolic dysfunction-associated steatohepatitis in mice
    (APASL Oncology 2024 Chiba (“Genomics Meets Immunology: Interdisciplinary Approach for Liver Cancer”))
  • 肝細胞癌との鑑別に苦慮し生検と同時にラジオ波焼灼療法を行った肝Adrenal rest tumorの一例
    (第60回日本肝癌研究会)
  • 去勢による男性ホルモン低下とフルクトース摂取による腸内細菌叢-内臓脂肪量-脂肪肝への影響
    (日本農芸化学会関西支部第531回講演会)
  • Metabolic dysfunction-associated steatohepatitisモデルマウスに対するプトレシンの効果
    (第60回日本肝臓学会総会)
  • 原発性胆汁性胆管炎、原発性硬化性胆管炎モデルマウスに対するハスカップ果実抽出物の効果
    (第60回日本肝臓学会総会)
more...
Education (3):
  • 1996 - 2000 Graduate School of the University of Tokyo Medicine Etiology and Pathology
  • 1992 - 1996 The University of Tokyo Faculty of Medicine School of Medicine
  • 1990 - 1992 The University of Tokyo College of Arts and Sciences
Professional career (1):
  • Doctor of Medical Science (The University of Tokyo)
Work history (6):
  • 2024/04 - 現在 Department of Molecular Pathology, Tokyo Medical University Professor
  • 2017/04 - 2024/03 Department of Pathology, School of Medicine, International University of Health and Welfare Professor
  • 2010/01 - 2017/03 Department of Pathology, Teikyo University School of Medicine Associate Professor
  • 2003/04 - 2009/12 Department of Pathology, Teikyo University School of Medicine Lecturer
  • 2001/04 - 2003/03 Department of Pathology, Tokyo University Hospital Assistant Professor
Show all
Committee career (7):
  • 2018/05 - 現在 Liver Cancer Editorial Board Member
  • 2018/05 - 現在 肝癌症例研究会 運営委員
  • 2015/06 - 現在 The Japanese Society of Clinical Cytology Councilor
  • 2015/01 - 現在 Pathology International Editorial Board Member
  • 2014/11 - 現在 The Japan Society of Hepatology Eastern Branch Councilor
Show all
Awards (5):
  • 2024/09 - The Asian Pacific Association for the Study of the Liver (APASL) Investigator Award Inhibitory effects of putrescine on metabolic dysfunction-associated steatohepatitis in mice
  • 2023/04 - 日本病理学会 学部学生ポスター優秀演題賞 原発性胆汁性胆管炎モデルマウスに対するハスカップ果実抽出物の改善効果
  • 2022/04 - 日本病理学会 学部学生ポスター優秀演題賞 非アルコール性脂肪性肝炎モデルマウスに対する漢方薬の改善効果
  • 2022/01 - Expertscape Expertscape Expert in Fatty Liver
  • 2006/07 - New Communications Who's Who in Medicine and Healthcare 2006-2007
Association Membership(s) (8):
Sigma Xi ,  TSOD(肥満・糖尿病)マウス研究会 ,  Liver Cancer Study Group of Japan ,  The Japan Society of Hepatology ,  肝癌症例研究会 ,  The Japanese Society of Clinical Cytology ,  The Japanese Society of Pathology ,  Japanese Cancer Association
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page